Status:
RECRUITING
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
Lead Sponsor:
Alliance Foundation Trials, LLC.
Collaborating Sponsors:
Memorial Sloan Kettering Cancer Center
Conditions:
Advanced Cancer
Metastatic Cancer
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The study aims to determine whether monthly remote digital financial hardship screening among adults with advanced/metastatic cancer, undergoing outpatient systemic therapy with non-curative intent, i...
Detailed Description
Financial hardship is a common problem that affects patients treated for advanced cancer and leads to poor outcomes related to financial worry, health related quality of life (HRQoL), symptom burden, ...
Eligibility Criteria
Inclusion
- Minimum age of 21
- Understands English and/or Spanish
- Has a diagnosis of advanced/metastatic cancer
- Currently undergoing systemic therapy (enteral or parenteral) with non-curative intent
- Has been receiving treatment for at least 2 months
- Life expectancy of at least 6 months, in the opinion of the treating oncologist
- Cognitively able to give informed consent
Exclusion
- Under the age of 21
- Does not understand English or Spanish
- Has cognitive deficits that would preclude understanding of consent form and/or questionnaires
- Undergoing treatment with curative intent (e.g., adjuvant chemotherapy for breast, lung, or ovarian cancer, primary curative therapy for testis cancer or lymphoma)
- Not undergoing systemic therapy (enteral or parenteral) with non-curative intent
- Receiving treatment for fewer than 2 months
- Life expectancy is less than 6 months, in the opinion of the treating oncologist
Key Trial Info
Start Date :
July 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2029
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06963723
Start Date
July 1 2025
End Date
April 1 2029
Last Update
December 9 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
New Hampshire Oncology-Hematology, PA
Concord, New Hampshire, United States, 03301
2
Solinsky Center for Cancer Care
Manchester, New Hampshire, United States, 03103